Other Mycobacterioses

  • Josemir Belo dos SantosEmail author
  • Márcia Helena de Oliveira
  • Perla Gomes da Silva
  • Vanessa Lucília Silveira de Medeiros


Mycobacterioses are infections caused by bacteria of the genus Mycobacterium. The nontuberculous mycobacteria (NTM) are environmental, Gram-positive, acid-fast bacilli that cause various manifestations in different groups of patients and can lead to a broad range of clinical disorders, from cutaneous infections, such as cervical or intrathoracic lymphadenitis in children, to disseminated infections at all ages. NTM infection has been an important cause of morbidity and mortality. Early diagnosis and initiation of treatment with multiple antibiotics for several months and potential use of adjunctive surgery are necessary to achieve the best outcome. In patients with AIDS who are not on antiretroviral therapy, Mycobacterium avium-intracellulare complex (MAC) disease typically is a disseminated, multi-organ infection.


Mycobacteriosis Mycobacterium Nontuberculous mycobacteria Mycobacterium infection Mycobacterium abscessus complex Mycobacterium fortuitum Mycobacterium avium-intracellulare complex Mycobacterium marinum Cutaneous tuberculosis 


  1. 1.
    Pavlik I, Falkinham JO III, Kazda J. Potentially pathogenic mycobacteria. In: Kazda J, Pavlik I, Falkinham III JO, Hruska K, editors. The ecology of mycobacteria: impact on animal’s and human’s health. Dordrecht: Springer; 2009. p. 21–79. doi: Scholar
  2. 2.
    Leao SC, Tortoli E, Euzéby JP, Garcia MJ. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol. 2011;61:2311–3. doi: Scholar
  3. 3.
    Jagielski T, van Ingen J, Rastogi N, Dziadek J, et al. Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int. 2014; doi:
  4. 4.
    Euzéby JP. List of prokaryotic names with standing in nomenclature (LPSN). Accessed 13 Feb 2016.
  5. 5.
    Ramos-e-Silva M, Castro CR. Mycobacterial infections. In: Bolognia JL, et al., editors. Dermatology. London: Sauders; 2012. p. 1221–42.Google Scholar
  6. 6.
    Bates TR, Keenher T, O’Reilly LC, Heath CH, et al. Extensive cutaneous Mycobacterium abscessus infection due to contaminated insulin delivery system. QJM. 2009;102:881–4. doi: Scholar
  7. 7.
    Slany M, Jezek P, Fiserova V, Bodnarova M, et al. Mycobacterium marinum infections in humans and tracing of its possible environmental sources. Can J Microbiol. 2012;58(1):39–44. doi: Scholar
  8. 8.
    Sousa PP, Cruz RCS, Schettini AP, Westphal DC. Mycobacterium abscessus skin infection after tattooing – case report. An Bras Dermatol. 2015;90(5):741–3. doi: Scholar
  9. 9.
    Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16(10):1576–83. doi: Scholar
  10. 10.
    Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med. 2002;23(3):553–67.CrossRefPubMedGoogle Scholar
  11. 11.
    Falkingham JO III, Norton CD, Le Chavallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67:1225–31. doi: Scholar
  12. 12.
    du Moulin GC, Stottmeier KD, Pelletier PA, Tsang AY, Hedley-Whyte J. Concentration of Mycobacterium avium by hospital hot water systems. JAMA. 1988;260(11):1599–601. doi: Scholar
  13. 13.
    Peters M, Müller C, Rüsch-Gerdes S, Seidel C, et al. Isolation of atypical mycobacteria from tap water in hospitals and homes: is this a possible source of disseminated MAC infection in AIDS patients? J Infect. 1995;31(1):39–44. doi: Scholar
  14. 14.
    Ross BC, Johnson PD, Oppedisano F, Marino L, et al. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol. 1997;63(10):4135–8.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Kubalek I, Mysak J. The prevalence of environmental mycobacteria in drinking water supply systems in a demarcated region in Czech Republic in the period 1984–1989. Eur J Epidemiol. 1996;12(5):471–4. doi: Scholar
  16. 16.
    Vaerewijck MJM, Huys G, Palomino JC, Swings J, et al. Mycobacteria in drinking water distribution systems: ecology and significance for human health. FEMS Microbiol Rev. 2005;29(5):911–34. doi: Scholar
  17. 17.
    Schulze-Röbbecke R, Feldmann C, Fischeder R, Janning B, et al. Dental units: an environmental study of sources of potentially pathogenic mycobacteria. Tuber Lung Dis. 1995;76(4):318–23. doi: Scholar
  18. 18.
    Ashford DA, Whitney E, Raghunathan P, Cosivi O. Epidemiology of selected mycobacteria that infect humans and other animals. Rev Sci Tech. 2001;20(1):325–37.CrossRefPubMedGoogle Scholar
  19. 19.
    Faria S, Joao I, Jordao L. General overview on nontuberculous mycobacteria, biofilms, and human infection. J Pathog. 2015;2015:809014. doi: Scholar
  20. 20.
    Kuritsky JM, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983;98:938–9. doi:\.CrossRefPubMedGoogle Scholar
  21. 21.
    Laussucq S, Baltch AL, Smith RP, et al. Nosocomial Mycobacterium fortuitum colonization from a contaminated ice machine. Am Rev Respir Dis. 1988;138:891–4. doi: Scholar
  22. 22.
    Panwalker AP, Fuhse E. Nosocomial Mycobacterium gordonae pseudoinfection from contaminated ice machines. Infect Control. 1986;7(2):67–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Burns DN, Wallace RJ Jr, Schultz ME, Zhang YS, et al. Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis. 1991;144(5):1153–9. doi: Scholar
  24. 24.
    Ide S, Nakamura S, Yamamoto Y, Kohno Y, et al. Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan. PLoS One. 2015;10(5):e0128304. doi: Scholar
  25. 25.
    Tebruegge M, Pantazidou A, MacGregor D, Gonis G, et al. Nontuberculous mycobacterial disease in children – epidemiology, diagnosis & management at a tertiary center. PLoS ONE. 2016;11(1):e0147513. doi: Scholar
  26. 26.
    Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi: Scholar
  27. 27.
    Lima CT, Magalhães V. Abscess resulting from Mycobacterium kansasii in the left thigh of AIDS patient. An Bras Dermatol. 2014;89(3):478–80. doi: Scholar
  28. 28.
    Macente S, Helbel C, Souza SFR, Siqueira VLD, et al. Disseminated folliculitis by Mycobacterium fortuitum in an immunocompetent woman. An Bras Dermatol. 2013;88(1):102–4. doi: Scholar
  29. 29.
    Serra C, Loi G, Saddi B, Pautasso M, Manzin A. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman. J Clin Microbiol. 2007;45:1663–5. doi: Scholar
  30. 30.
    Wildner LM, Bazzo ML, Liedke SC, Nogueira CL, et al. Mycobacteria mobility shift assay: a method for the rapid identification of Mycobacterium tuberculosis and nontuberculous mycobacteria. Mem Inst Oswaldo Cruz. 2014;109(3):356–61. doi: Scholar
  31. 31.
    Neves RG, Pradinaud R. Micobacterioses atipicas. In: Neves RG, Talhari S, editors. Dermatologia tropical. Rio de Janeiro: Medsi; 1995. p. 283–90.Google Scholar
  32. 32.
    Azulay RD, Azulay DR, Azulay-Abulafia L. Micobacterioses. In: Azulay RD, Azulay DR, Azulay-Abulafia L, editors. Dermatologia. Rio de Janeiro: Guanabara Koogan; 2011. p. 349–76. Accessed 28 Feb 2016.Google Scholar
  33. 33.
    Sampaio SAP, Rivitti E, et al. Micobacterioses. In: Sampaio SAP, Rivitti E, editors. Dermatologia. Rio de Janeiro: Guanabara Koogan; 2001. p. 345–6.Google Scholar
  34. 34.
    Brasil. Agência Nacional de Vigilância Sanitária. Nota técnica conjunta N° 01/2009. Infecções por micobactérias de crescimento rápido: fluxo de notificações, diagnósticos clínico, microbiológico e tratamento, 2009. Disponível em: Acesso em: nov/2009.
  35. 35.
    Nguyen HH, Fadul N, Ashraf MS, Siraj DS. Osteomyelitis infection of Mycobacterium marinum: a case report and literature review. Case Rep Infect Dis. 2015;2015:905920. doi: Scholar
  36. 36.
    Oh HW, Youn SH, Kim MS, Na CH, et al. Mycobacterium marinum infection on the face diagnosed by polymerase chain reaction amplification and direct sequencing. Ann Dermatol. 2015;27(5):639–41. doi: Scholar
  37. 37.
    Yano Y, Kitada S, Mori M, Kagami S, et al. Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan. Respiration. 2013;85(4):305–11. doi: Scholar
  38. 38.
    Zhang X, Liu W, Liu W, Jiang H, et al. Cutaneous infections caused by rapidly growing mycobacteria: case reports and review of clinical and laboratory aspects. Acta Derm Venereol. 2015;95(8):985–9. doi: Scholar
  39. 39.
    Suvanasuthi S, Wongpraparut C, Pattanaprichakul P, Bunyaratavej S. Mycobacterium fortuitum cutaneous infection from amateur tattoo. J Med Assoc Thail. 2012;95(6):834–7. doi: Scholar
  40. 40.
    Quiñones C, Ramalle-Gómara E, Perucha M, Lezaun ME, et al. An outbreak of Mycobacterium fortuitum cutaneous infection associated with mesotherapy. J Eur Acad Dermatol Venereol. 2010;24(5):604–6. doi: Scholar
  41. 41.
    Olivares L, Fandiño M, Pardal PF, Cortiñas MEP, et al. Infección cutánea por Mycobacterium chelonae. Dermatol Argent. 2011;17(6):446–50.Google Scholar
  42. 42.
    Murback ND, Higa Júnior MG, Pompílio MA, Cury ESJ, et al. Disseminated cutaneous atypical mycobacteriosis by M. chelonae after sclerotherapy of varicose veins in a immunocompetent patient: a case report. An Bras Dermatol. 2015;90(3 Suppl 1):S138–42. doi: Scholar
  43. 43.
    Bechara C, Macheras E, Heym B, Pages A, et al. Mycobacterium abscessus skin infection after tattooing: first case report and review of the literature. Dermatology. 2010;221(1):1–4. doi: Scholar
  44. 44.
    Wongkitisophon P, Rattanakaemakorn P, Tanrattanakorn S, Vachiramon V. Cutaneous Mycobacterium abscessus infection associated with mesotherapy injection. Case Rep Dermatol. 2011;3(1):37–41. doi: Scholar
  45. 45.
    Wu TS, Yang CH, Brown-Elliott BA, Chao AS, et al. Postcesarean section wound infection caused by Mycobacterium massiliense. J Microbiol Immunol Infect. 2015;S1684–1182(15):00821-X. doi: Scholar
  46. 46.
    Deshayes C, Angala SK, Marion E, Brandli I, et al. Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source. PLoS Negl Trop Dis. 2013;7(11):e2502. doi: Scholar
  47. 47.
    Adu EJ. Management of complications of Mycobacterium ulcerans disease: a three-year review. Int J Mycobacteriol. 2013;2(4):206–10. doi: Scholar
  48. 48.
    Pszolla N, Sarkar MR, Strecker W, Kern P, et al. Buruli ulcer: a systemic disease. Clin Infect Dis. 2003;37(6):e78–82.CrossRefPubMedGoogle Scholar
  49. 49.
    Kassi K, Kouame K, Allen W, Kouassi LA, et al. Squamous cell carcinoma secondary to Buruli ulcer: a clinical case report in a young girl. Bacteriol Virusol Parazitol Epidemiol. 2010;55(1):25–8.PubMedGoogle Scholar
  50. 50.
    Kaplan JE, Benson C, Holmes KK, Brooks JT, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Atlanta; 2009. 198p. Accessed 18 Feb 2016.
  51. 51.
    Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005;5(6):361–73. doi: Scholar
  52. 52.
    Kollipara R, Richards K, Tschen J, Campbell L, et al. Disseminated Mycobacterium avium complex with cutaneous lesions. J Cutan Med Surg. 2016; doi:
  53. 53.
    Wood BR, Buitrago MO, Patel S, Hachey DH, et al. Mycobacterium avium complex osteomyelitis in persons with human immunodeficiency virus: case series and literature review. Open Forum Infect Dis. 2015;2(3):ofv090. doi: Scholar
  54. 54.
    Formanoy E, Lam HY, Arends JE. Tenosynovitis of the right hand. Mycobacterium kansasii. Neth J Med. 2013;71(10):526–30.PubMedGoogle Scholar
  55. 55.
    Shaaban H, Layne T, Sensakovic JW, Boghossian J. Mycobacterium kansasii septicemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure. Int J STD AIDS. 2014;25(2):152–4. doi: Scholar
  56. 56.
    Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with longterm follow-up. Clin Infect Dis. 1995;20(4):954–63. doi: Scholar
  57. 57.
    Amir J. Non-tuberculous mycobacterial lymphadenitis in children: diagnosis and management. IMAJ. 2010;12(1):49–52.PubMedGoogle Scholar
  58. 58.
    Raffaldi I, Scolfaro C, Garazzino S, Peradotto F, et al. An atypical deep neck infection in a two-year-old child. Infez Med. 2014;22(2):136–9.PubMedGoogle Scholar
  59. 59.
    Nolt D, Michaels MG, Wald ER. Intrathoracic disease from nontuberculous mycobacteria in children: two cases and a review of the literature. Pediatrics. 2003;112(5):e434. doi: Scholar
  60. 60.
    van Ingen J, Boeree MJ, de Lange WC, de Haas PE, et al. Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis. 2008;46(8):1200–5. doi: Scholar
  61. 61.
    Singh AK, Marak RS, Maurya AK, Das M, et al. Mixed cutaneous infection caused by Mycobacterium szulgai and Mycobacterium intermedium in a healthy adult female: a rare case report. Case Rep Dermatol Med. 2015;2015:607519. doi: Scholar
  62. 62.
    Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, Prins JM, et al. Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev. 2011;24(4):701–17. doi: Scholar
  63. 63.
    Atiya N, Sulaiman H, Chong J, Ng KP. First report of cervicofacial lymphadenitis due to Mycobacterium haemophilum in an immunocompromised adult patient. J Infect Dev Countries. 2015;9(3):313–6. doi: Scholar
  64. 64.
    Bachmeyer C, Blum L, Stelianides S, Benchaa B, et al. Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment. Thorax. 2001;56(12):978–9. doi: Scholar
  65. 65.
    Pigem R, Cairó M, Martínez-Lacasa X, Irigoyen D, et al. Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient. J Am Acad Dermatol. 2013;69(4):e192–3. doi: Scholar
  66. 66.
    Lhuillier E, Brugière O, Veziris N, Danel C, et al. Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literature. Exp Clin Transplant. 2012;10(6):618–20. doi: Scholar
  67. 67.
    Charles P, Lortholary O, Dechartres A, Doustdar F, et al. Mycobacterium genavense infections: a retrospective multicenter study in France, 1996–2007. Medicine (Baltimore). 2011;90(4):223–30. doi: Scholar
  68. 68.
    Bombarda S, Chimara E, Seiscento M, Oliveira MLV, et al. Recomendações para o diagnóstico e tratamento das micobacterioses não tuberculosas no estado de São Paulo. São Paulo; 2005. Accessed 26 Feb 2016.
  69. 69.
    Esteban J, Garcia-Pedrazuela M, Muñoz-Egea MC, Alcaide F. Current treatment of nontuberculous mycobacteriosis: an update. Expert Opin Pharmacother. 2012;13(7):967–86. doi: Scholar
  70. 70.
    Wildner LM, Walnut CL, Souza BS, Senna SG, Silva RM, Bazzo ML. Mycobacteria: epidemiology and diagnosis. J Trop Pathol. 2011;40(3):207–29. Accessed 26 Feb 2016 Google Scholar
  71. 71.
    Brown-Elliott BA, Nash KA, Wallace RJ Jr. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25(3):545–82. doi: Scholar
  72. 72.
    Yotsu RR, Murase C, Sugawara M, Suzuki K, et al. Revisiting Buruli ulcer. J Dermatol. 2015;42(11):1033–41. doi: Scholar
  73. 73.
    Soini H, Musser JM. Molecular diagnosis of mycobacteria. Clin Chem. 2001;47(5):809–14.PubMedGoogle Scholar
  74. 74.
    Escobar-Escamilla N, Ramírez-González JE, González-Villa M, Torres-Mazadiego P, et al. Hsp65 phylogenetic assay for molecular diagnosis of nontuberculous mycobacteria isolated in Mexico. Arch Med Res. 2014;45(1):90–7. doi: Scholar
  75. 75.
    Bartralot R, Pujol RM, García-Patos V, Sitjas D, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol. 2000;27(3):124–9. doi: Scholar
  76. 76.
    Song H, Lee H, Choi G, Shin J. Cutaneous nontuberculous mycobacterial infection: a clinicopathological study of 7 cases. Am J Dermatopathol. 2009;31(3):227–31. doi: Scholar
  77. 77.
    Dodiuk-Gad R, Dyachenko P, Ziv M, Shani-Adir A, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol. 2007;57(3):413–20. doi: Scholar
  78. 78.
    Bau AEK. Micobacterioses Não Tuberculosas. In: Lupi O, Santos JB, Cunha PR, editors. Rotinas de Diagnóstico e Tratamento da Sociedade Brasileira de Dermatologia. 1st ed. São Paulo: GEN; 2010. p. 326–31.Google Scholar
  79. 79.
    Lan NPH, Kolader ME, Dung NV, Campbell JI, et al. Mycobacterium fortuitum skin infections after subcutaneous injections with Vietnamese traditional medicine: a case report. BMC Infect Dis. 2014;14:550. doi: Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  • Josemir Belo dos Santos
    • 1
    Email author
  • Márcia Helena de Oliveira
    • 1
  • Perla Gomes da Silva
    • 1
  • Vanessa Lucília Silveira de Medeiros
    • 1
  1. 1.Federal University of PernambucoRecifeBrazil

Personalised recommendations